Navigation Links
Kineta to Present at Symposium on Pandemic Preparedness
Date:6/12/2017

SEATTLE, June 12, 2017 /PRNewswire/ -- Kineta, Inc., a biotechnology company focused on the development of novel immuno-therapies, today announced Kineta Vice President of R&D and Head of Virology Kristin Bedard has been invited to present at the Pandemic Preparedness for the Northwest and Beyond meeting sponsored by Life Science Washington.  This Symposium will be held on June 14, 2017 from 8:30-10:30 AM PDT at the Agora Conference Center in Seattle, WA.

Dr. Bedard will be joined by other leaders in infectious disease research and the global health community in discussing new approaches to developing drugs and vaccines that will address future pandemic threats. She will present an overview of Kineta's portfolio and highlight LHF-535, Kineta's first in class antiviral for Lassa Hemorrhagic Fever as well as the company's vaccine adjuvant program.  

This symposium will discuss threat prediction models, new medical and pharmaceutical research, the role of animals in disease outbreaks along with the roles of local measures, citizens, and businesses in helping mitigate outbreaks.  

Click here to learn more about this event. 

Kineta, Inc. is an emerging biotech company that fills a void in the biopharmaceutical industry by efficiently advancing first in class immuno-therapies from discovery to proof of concept.  Kineta is developing a focused pipeline of novel therapies that address critical unmet patient needs in oncology, chronic pain and biodefense. We actively collaborate with a broad array of private, government, biodefense and industry partners to advance our innovative research. For more information on Kineta, Inc. visit our website, www.Kinetabio.com

NOTICE: This document contains certain forward-looking statements, including without limitation statements regarding Kineta's plans for pre-clinical and clinical studies, regulatory filings, and anticipated drug effects in human subjects. You are cautioned that such forward-looking statements are not guarantees of future performance and involve risks and uncertainties inherent in Kineta's business which could significantly affect expected results, including without limitation progress of drug development, ability to raise capital to fund drug development, clinical testing and regulatory approval, developments in raw material and personnel costs, and legislative, fiscal, and other regulatory measures. All forward-looking statements are qualified in their entirety by this cautionary statement, and Kineta undertakes no obligation to revise or update any forward-looking statement to reflect events or circumstances after the issuance of this press release.

Contact Jacques Bouchy
163942@email4pr.com
(206) 378-0400

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/kineta-to-present-at-symposium-on-pandemic-preparedness-300472439.html


'/>"/>
SOURCE Kineta, Inc.
Copyright©2017 PR Newswire.
All rights reserved


Related medicine technology :

1. Kineta Presents Promising New Data on Novel Lassa Fever Antiviral and Broad Spectrum Innate Immune Antivirals
2. Lillys Galcanezumab Significantly Reduces Number of Migraine Headache Days for Patients with Migraine: New Results Presented at AHS
3. DarioHealth to Present at the 7th Annual LD Micro Invitational
4. Hill-Rom to Present at the Goldman Sachs 38th Annual Global Healthcare Conference
5. Therapix Biosciences to Present at Upcoming Scientific and Investor Conferences in June
6. Endo to Present at Goldman Sachs 38th Annual Global Healthcare Conference
7. Zimmer Biomet Holdings to Present at 42nd Annual Deutsche Bank Securities Annual Health Care Conference
8. RXi Pharmaceuticals to Present an Update on its Consumer Product Development Programs at the Society for Investigative Dermatology 76th Annual Meeting
9. NeuroVive Presents Preclinical Findings of NV556 in NASH Showing Confirmatory Anti-fibrotic Effects
10. CRH Medical Corporation To Present at the Bloom Burton & Co. Healthcare Investor Conference
11. Astute Medical, Inc. Previews Scientific Presentation At Upcoming National Kidney Foundation Spring Clinical Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/9/2017)... INDIANAPOLIS , June 9, 2017 More ... a further effort to help spread lessons learned from ... the International Diabetes Federation (IDF) and Eli Lilly and ... for the second phase of the Bringing Research in ... reaffirming their commitment to helping people with diabetes effectively ...
(Date:6/8/2017)... 2017   Responding to Heath Ledger,s father,s ... of singer Chris Cornell in May, the mental ... a free online psychiatric drug side effects ... about psychotropic drug risks. The father of ... an accidental overdose, has called for tighter rules on prescription ...
(Date:6/7/2017)... , June 7, 2017 Endo International plc ... 7, 2017, the Hon. Joseph R. Goodwin , ... West Virginia , entered a case ... Pelvic Repair System Products Liability Litigation (the "MDL") that ... cases to provide expert disclosures on specific causation within ...
Breaking Medicine Technology:
(Date:6/25/2017)... ... June 25, 2017 , ... CareSet Labs released the Root NPI Graph today ... a new, greatly improved version of the Doctor Referral teaming dataset commonly available from ... and subsequently called the the “Doctor Referral Dataset” as released by Medicare and “DocGraph” ...
(Date:6/24/2017)... ... June 24, 2017 , ... The Pennsylvania Athletic ... Erie Bayfront and Erie Convention Center on June 8-10. The weekend consisted ... quiz bowl, award and scholarship presentations, and professional networking. , On Friday ...
(Date:6/23/2017)... ... June 23, 2017 , ... The Rhode Island ... Care Management Alerts and Dashboards, an innovative new service enabling healthcare providers to ... Care Management Alerts and Dashboards provide near real-time data about patients admitted to ...
(Date:6/23/2017)... ... June 24, 2017 , ... Studies show evidence that carotenoids ... risk of visual loss in these patients. , But how often do ophthalmologists and ... cessation to patients at risk of or with early symptoms of AMD? A ...
(Date:6/23/2017)... ... 2017 , ... Everybody has their own personal preference when it comes to ... some people don't like it at all. FindaTopDoc took a look at what makes ... can give readers a taste of their deepest, darkest fantasies and has the ability ...
Breaking Medicine News(10 mins):